This is an outdated version published on 19-12-2025. Read the most recent version.

Bioanalysis of chrysin in human plasma and analytical stability using validated UV-spectrophotometric method:

a quality by design approach

Authors

  • Rohini Pargonda Patil KLE College of Pharmacy, Belagavi, KLE Academy of Higher Education and Research, Belagavi, Karnataka, India https://orcid.org/0009-0005-9987-2312
  • Shailendra Sanjay Suryawanshi KLE College of Pharmacy, Belagavi, KLE Academy of Higher Education and Research, Belagavi, Karnataka, India https://orcid.org/0000-0003-1646-8815
  • Mahesh Shivabasappa Palled KLE College of Pharmacy, Belagavi, KLE Academy of Higher Education and Research, Belagavi, Karnataka, India https://orcid.org/0000-0002-9223-5653

DOI:

https://doi.org/10.22456/2527-2616.148193

Keywords:

Bioanalysis, chrysin, quality by design, human plasma, UV-Visible spectrophotometer.

Abstract

Chrysin is a flavonoid with many biological and medicinal activities, such as anti-cancer, anti-inflammatory, anti-diabetic,
and antioxidant properties, and has medicinal value. Based on the Quality by Design approach, the present study used a
UV-spectrophotometer to develop a bioanalytical method for chrysin in human plasma. The validation of the method was
performed as per ICH M10 guidelines. The technique was performed using methanol as a solvent and the spectrum was
recorded at a wavelength of 370 nm. The spiked chrysin from plasma was extracted using the protein precipitation method.
The developed method was linear with an r2 value of 0.9996 over a concentration range of 4-20 μg/ml. The results of all
validation parameters are found to be within the accepted limits with a % RSD value of less than 2% and the % recovery
was greater than 95%. The % RSD and % recovery results confirmed that the method was precise and accurate in the study.
LOD and LOQ values in plasma samples were found to be 0.47 μg/ml and 1.43 μg/ml respectively. The stability studies
like freeze-thaw, and short-term stability studies were also performed and proved the reliability of the method. Therefore,
the developed bioanalytical method can effectively estimate chrysin in plasma samples within its sensitivity limits.

Downloads

Download data is not yet available.

References

Deshpande M, Kasture V, Mohan M, Chavan M. Bioanalytical method development and validation: a. Review. In: Ince M, Ince OK, editors. Recent Advances in Analytical Chemistry. 1 ed. Turkey; IntechOpen. 2019.

Thakur A, Tan Z, Kameyama T, El-Khateeb E, Nagpal S, Malone S,et al. Bioanalytical strategies in drug discovery and development. Drug Metab. Rev. 2021; 53(3):434-458. DOI: https://doi.org/10.1080/03602532.2021.1959606

Rudrapal M, Kothawade A, Ezzat S, Egbuna C. Bioanalysis: methods, techniques, and applications. In Analytical Techniques in Biosciences. 1 ed. Academic Press, 2022. p. 1-24. DOI: https://doi.org/10.1016/B978-0-12-822654-4.00002-6

Moein M, El Beqqali A, Abdel-Rehim MA. Bioanalytical method development and validation: Critical concepts and strategies. J. Chromatogr. 2017; 1043:3-11. DOI: https://doi.org/10.1016/j.jchromb.2016.09.028

Meesters, RJ. Voswinkel, S. Bioanalytical Method Development and Validation: From the USFDA 2001 to the USFDA 2018 Guidance for Industry. J. Appl. Bioanal. 2018, 4, 67–73. DOI: https://doi.org/10.17145/jab.18.010

Saudagar R, Thete P. Bioanalytical method validation: a concise review. Asian J Res Pharm Sci. 2018; 8 (2):101-114. DOI: https://doi.org/10.5958/2231-5659.2018.00019.X

Hasnat H, Shompa S, Islam M, Alam S, Richi F, Emon N, et al. Flavonoids: A treasure house of prospective pharmacological potentials. Heliyon. 2024; 10(6): 1-28. DOI: https://doi.org/10.1016/j.heliyon.2024.e27533

Singla R, Dubey A, Garg A, Sharma R, Fiorino M, Ameen S, et al. Natural polyphenols: Chemical classification, definition of classes, subcategories, and structures. J AOAC Int. 2019;102(5):1397–1400. DOI: https://doi.org/10.5740/jaoacint.19-0133

Billowria K, Ali R, Rangra NK, Kumar R, Chawla PA. Bioactive flavonoids: a comprehensive review on pharmacokinetics and analytical aspects. Crit. Rev. Anal. Chem. 2024; 54(5):1002-1016.

Liga S, Paul C, Péter F. Flavonoids: Overview of biosynthesis, biological activity, and current extraction techniques. Plants. 2023; 12(14): 1-25. DOI: https://doi.org/10.3390/plants12142732

Naz S, Imran M, Rauf A, Orhan IE, Shariati MA, Shahbaz M, et al. Chrysin: Pharmacological and therapeutic properties. Life sciences. 2019; 235: 1-10. DOI: https://doi.org/10.1016/j.lfs.2019.116797

Mani R, Natesan V. Chrysin: Sources, beneficial pharmacological activities, and molecular mechanism of action. Phytochemistry. 2018; 145: 187-196. DOI: https://doi.org/10.1016/j.phytochem.2017.09.016

Dong X, Cao Y, Wang N, Wang P, Li M. Systematic study on solubility of chrysin in different organic solvents: The synergistic effect of multiple intermolecular interactions on the dissolution process. J. Mol. Liq. 2021; 325: DOI: https://doi.org/10.1016/j.molliq.2020.115180

Mohammed HA, Sulaiman GM, Albukhaty S, Al‐Saffar AZ, Elshibani FA, Ragab EA. Chrysin, the flavonoid molecule of antioxidant interest. Chemistry Select. 2023; 8(48): 1-15. DOI: https://doi.org/10.1002/slct.202303306

El-Aziz HA, Hammouda NE, Belal F, Elama HS. Eco-Friendly Analytical Approach for Sensitive Spectrofluorimetric Determination of the Flavonoid Chrysin in Capsules and Human Plasma. J. Fluoresc. 2024:1-10. DOI: https://doi.org/10.1007/s10895-024-03962-9

Harshini S, Sudha T. Qbd-Quality by Design Analytical Method Development and Validation Overview. Rasayan J. Chem. 2024; 17(3): 1309-1314. DOI: https://doi.org/10.31788/RJC.2024.1738778

Bairagi A, Kothrukar R, Chikhale H, Kosanam S, Borse L. AQbD-novel strategy for analytical methods. Future J. Pharm. Sci. 2024 Oct 4;10 (1):138. DOI: https://doi.org/10.1186/s43094-024-00706-1

Singh AK, Vashitha Y, Jain A, Gupta GD, Verma SK. A Review on Advancement in Analytical Quality by Design (AQbD). Bentham Science. 2024; 21(8): 901-922. DOI: https://doi.org/10.2174/0115734110321580240924073705

Chiarentin L, Gonçalves C, Augusto C, Miranda M, Cardoso C, Vitorino C. Drilling into “Quality by Design” approach for analytical methods. Crit Rev Anal Chem. 2024; 54(8):3478-3519. DOI: https://doi.org/10.1080/10408347.2023.2253321

Harish V, Almalki WH, Alshehri A, Alzahrani A, Alzarea SI, Kazmi I, Gulati M, Tewari D, Chellappan DK, Gupta G, Dua K. Bioanalytical method development, validation and stability assessment of xanthohumol in rat plasma. Molecules. 2022; 27 (20):1-12. DOI: https://doi.org/10.3390/molecules27207117

Kumar N, Sangeetha D. Analytical method development by using QbD-An emerging approach for robust analytical method development. J. Pharm. Sci. Res. 2020; 12(10):1298-1305.

International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). Bioanalytical method validation M10 – Step 4. Geneva; 2022.

Downloads

Published

19-12-2025

Versions

How to Cite

Pargonda Patil, R., Sanjay Suryawanshi, S., & Shivabasappa Palled, M. (2025). Bioanalysis of chrysin in human plasma and analytical stability using validated UV-spectrophotometric method:: a quality by design approach. Drug Analytical Research, 9(2), 3–12. https://doi.org/10.22456/2527-2616.148193

Issue

Section

ORIGINAL ARTICLES